相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of mutations in Escherichia coli PBP2 leading to increased carbapenem MICs
Felix Lange et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
In Vitro Activity of LYS228, a Novel Monobactam Antibiotic, against Multidrug-Resistant Enterobacteriaceae
Johanne Blais et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae
Charles R. Dean et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Carbapenemase-Producing Organisms: A Global Scourge
Robert A. Bonomo et al.
CLINICAL INFECTIOUS DISEASES (2018)
Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014
Orjan Samuelsen et al.
PLOS ONE (2017)
Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Unusual Escherichia coli PBP 3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae Tested In Vitro with a Combination of Ceftazidime-, Ceftaroline-, or Aztreonam-Avibactam
Yunliang Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with beta-Lactams against OP0595-Resistant Enterobacteriaceae Mutants
David M. Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain
Nejla Aissa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding Proteins
Andrew M. King et al.
ACS CHEMICAL BIOLOGY (2016)
Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli
Marlen Adler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Amdinocillin (Mecillinam) Resistance Mutations in Clinical Isolates and Laboratory-Selected Mutants of Escherichia coli
Elisabeth Thulin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3
Richard A. Alm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'
Akihiro Morinaka et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Correlation between penicillin-binding protein 2 mutations and carbapenem resistance in Escherichia coli
Shinichiro Yamachika et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Development of New Drugs for an Old Target - The Penicillin Binding Proteins
Astrid Zervosen et al.
MOLECULES (2012)
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Neil Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
Ken Coleman
CURRENT OPINION IN MICROBIOLOGY (2011)
Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa
Todd A. Davies et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Eric Sauvage et al.
FEMS MICROBIOLOGY REVIEWS (2008)
Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110
Koji Hayashi et al.
MOLECULAR SYSTEMS BIOLOGY (2006)
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
KA Datsenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
